Lilly, AbbVie, Merck, the Alzheimer’s Drug Discovery Foundation, and leading technology companies join the first platform study assessing various biomarker tests’ ability to predict the presence of Alzheimer’s Washington, DC (April 20, 2021) – Today, the Global...
The partnership will enable clinical trials and the collection of large, deeply phenotyped data-sets to better inform patient outcomes in Migraine, Multiple Sclerosis, Parkinson’s and other diseases SCOTTSDALE, ARIZ. & SINGAPORE–(BUSINESS...
Study results will be the basis of multiple regulatory submissions to the FDA, further expanding Aural Analytics’ suite of best-in-class speech-based clinical tools SCOTTSDALE, Ariz.–(BUSINESS WIRE)–Aural Analytics, Inc., the industry leader in speech...
The patent covers key systems and methods for the evaluation of disease onset, disease progression or disease treatment efficacy The patent also protects the use of any subjective or traditional clinical outcome measures in the development of speech-based algorithms...
Integration partnership enables seamless, embedded speech collection and analytics inside Signant Health’s widely used suite of software and hardware solutions PHILADELPHIA & SCOTTSDALE, Ariz.–(BUSINESS WIRE)– Aural Analytics, Inc., an industry...
